AKBA

AKEBIA THERAPEUTICS INC

Healthcare | Small Cap

-$0.01

EPS Forecast

$56.28

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.01

Revenue Forecast:

$56.28

EPS Surprise Forecast:

$0.000

Revenue Surprise Forecast:

$2

Post-release price volatility - Very high

Post-release Overnight Move:

±11.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

51%

Probability of beating revenue consensus:

68%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

21%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.22

Earnings volatility

EPS standard deviation:

$0.04

Revenue standard deviation:

$10

As % of share price:

2.55% VERY HIGH

As % of market cap:

2.62% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$0.03

Revenue 95th %ile:

$68

EPS 75th %ile:

-$0.00

Revenue 75th %ile:

$59

EPS 25th %ile:

-$0.02

Revenue 25th %ile:

$54

EPS 5th %ile:

-$0.06

Revenue 5th %ile:

$46

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

37% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$110

Bid-ask per Share:

$0.015